Antimicrobial Resistance Surveillance Market is estimated to increase at a Compounded Annual Growth Rate of 6.1% CAGR over the forecast period from 2024 to 2030
The Antimicrobial Resistance Surveillance Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Others), By End-User (Hospitals & Clinics, Research & Academic Institutes, Others).
An Introduction to Antimicrobial Resistance Surveillance Market in 2024
Antimicrobial resistance surveillance plays a crucial role in monitoring the emergence and spread of resistant pathogens, guiding infection control measures, and informing antimicrobial stewardship programs to preserve the effectiveness of antimicrobial agents. In 2024, surveillance efforts encompass a comprehensive approach to collecting, analyzing, and disseminating data on antimicrobial resistance patterns in human and animal populations, as well as in the environment. These surveillance systems utilize laboratory-based methods, epidemiological surveys, and genomic sequencing techniques to track resistance trends, identify hotspots of resistance emergence, and assess the impact of interventions aimed at curbing antimicrobial resistance. With global collaboration and coordination, antimicrobial resistance surveillance informs evidence-based policies, drives research priorities, and facilitates international efforts to combat antimicrobial resistance, safeguarding public health and preserving the effectiveness of antimicrobial agents for future generations.
Market Trend: Increased Global Awareness and Collaboration
One prominent trend in the antimicrobial resistance surveillance market is increased global awareness and collaboration. With the growing threat posed by antimicrobial resistance (AMR) to public health worldwide, there is heightened awareness among governments, healthcare organizations, and international agencies about the urgent need to address this issue. This trend is driving collaboration and coordination efforts at national, regional, and global levels to establish comprehensive surveillance systems for monitoring antimicrobial resistance patterns, tracking resistant bacteria, and identifying emerging resistance trends. Enhanced surveillance capabilities facilitate data sharing, information exchange, and evidence-based decision-making to guide antimicrobial stewardship initiatives, infection control strategies, and public health interventions aimed at combating AMR on a global scale.
Market Driver: Rising Incidence of Multidrug-Resistant Infections
A significant driver in the antimicrobial resistance surveillance market is the rising incidence of multidrug-resistant infections. As antimicrobial resistance continues to escalate, healthcare systems worldwide are facing increasing challenges in treating common bacterial infections due to the proliferation of multidrug-resistant pathogens. These pathogens exhibit resistance to multiple classes of antibiotics, limiting treatment options and posing significant threats to patient outcomes, healthcare resources, and public health. The urgent need to monitor and respond to the spread of multidrug-resistant infections drives the demand for antimicrobial resistance surveillance systems and tools that enable timely detection, tracking, and management of resistant bacteria in healthcare settings and communities.
Market Opportunity: Integration of Genomic Surveillance and Big Data Analytics
An emerging opportunity in the antimicrobial resistance surveillance market is the integration of genomic surveillance and big data analytics. Advances in genomic sequencing technologies and bioinformatics tools have revolutionized the field of antimicrobial resistance surveillance by enabling rapid and high-resolution characterization of resistant bacteria at the genetic level. Genomic surveillance allows for the identification of resistance mechanisms, transmission dynamics, and genetic determinants of antimicrobial resistance, providing valuable insights into the evolution and spread of resistant pathogens. By leveraging big data analytics and machine learning algorithms, antimicrobial resistance surveillance systems can analyze large-scale genomic and epidemiological datasets to detect patterns, predict trends, and inform targeted interventions for controlling AMR. This presents an opportunity for technology developers, healthcare providers, and public health agencies to collaborate on developing integrated surveillance platforms that harness the power of genomics and data analytics to enhance antimicrobial resistance surveillance capabilities, support evidence-based decision-making, and mitigate the impact of AMR on global health.
Antimicrobial Resistance Surveillance Market Share Analysis: Surveillance Software is the fastest growing segment over the forecast period to 2030
Among the segments in the Antimicrobial Resistance Surveillance Market, the Surveillance Software segment is experiencing the fastest growth. This growth can be attributed to several factors driving the demand for surveillance software solutions tailored to antimicrobial resistance (AMR) monitoring and management. Firstly, there's an increasing recognition of the urgent need to combat the global threat of antimicrobial resistance, which poses significant challenges to healthcare systems, patient care, and public health. Surveillance software plays a critical role in facilitating the collection, analysis, and interpretation of antimicrobial resistance data from various sources, including clinical laboratories, hospitals, and public health agencies. These software solutions enable real-time monitoring of antimicrobial resistance patterns, identification of emerging resistance trends, and timely interventions to prevent the spread of resistant pathogens and optimize antimicrobial therapy. Additionally, advancements in data analytics, artificial intelligence, and machine learning technologies enhance the capabilities of surveillance software to detect subtle changes in antimicrobial resistance patterns and predict future trends, thereby guiding antimicrobial stewardship efforts and resource allocation. Furthermore, regulatory initiatives and government mandates aimed at improving antimicrobial resistance surveillance and reporting drive the adoption of surveillance software solutions among healthcare providers, research institutions, and public health agencies. As stakeholders increasingly prioritize the implementation of comprehensive antimicrobial resistance surveillance programs to inform evidence-based interventions and policies, the Surveillance Software segment is expected to sustain its rapid growth trajectory in the Antimicrobial Resistance Surveillance Market.
Antimicrobial Resistance Surveillance Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Accelerate Diagnostics Inc, Alifax S.r.l., Becton, Dickinson and Company, Bioanalyse GmbH, bioMérieux SA, Bio-Rad Laboratories Inc, BioSpace Inc, Bruker Corp, Danaher Corp, Danaher Corp, F. Hoffmann-La Roche Ltd, Liofilchem S.r.l., Lumed LLC, Luminex Corp, Merck KGaA, OpGen Inc, QIAGEN N.V., Thermo Fisher Scientific Inc, Wolters Kluwer N.V.
Antimicrobial Resistance Surveillance Market Segmentation
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Antimicrobial Resistance Surveillance Market Companies
Abbott Laboratories
Accelerate Diagnostics Inc
Alifax S.r.l.
Becton, Dickinson and Company
Bioanalyse GmbH
bioMérieux SA
Bio-Rad Laboratories Inc
BioSpace Inc
Bruker Corp
Danaher Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Liofilchem S.r.l.
Lumed LLC
Luminex Corp
Merck KGaA
OpGen Inc
QIAGEN N.V.
Thermo Fisher Scientific Inc
Wolters Kluwer N.V.
Reasons to Buy the Antimicrobial Resistance Surveillance Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Antimicrobial Resistance Surveillance Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Antimicrobial Resistance Surveillance Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Antimicrobial Resistance Surveillance Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Antimicrobial Resistance Surveillance Market Size Outlook, $ Million, 2021 to 2030
3.2 Antimicrobial Resistance Surveillance Market Outlook by Type, $ Million, 2021 to 2030
3.3 Antimicrobial Resistance Surveillance Market Outlook by Product, $ Million, 2021 to 2030
3.4 Antimicrobial Resistance Surveillance Market Outlook by Application, $ Million, 2021 to 2030
3.5 Antimicrobial Resistance Surveillance Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Antimicrobial Resistance Surveillance Industry
4.2 Key Market Trends in Antimicrobial Resistance Surveillance Industry
4.3 Potential Opportunities in Antimicrobial Resistance Surveillance Industry
4.4 Key Challenges in Antimicrobial Resistance Surveillance Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Antimicrobial Resistance Surveillance Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Antimicrobial Resistance Surveillance Market Outlook by Segments
7.1 Antimicrobial Resistance Surveillance Market Outlook by Segments, $ Million, 2021- 2030
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
8 North America Antimicrobial Resistance Surveillance Market Analysis and Outlook To 2030
8.1 Introduction to North America Antimicrobial Resistance Surveillance Markets in 2024
8.2 North America Antimicrobial Resistance Surveillance Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Antimicrobial Resistance Surveillance Market size Outlook by Segments, 2021-2030
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
9 Europe Antimicrobial Resistance Surveillance Market Analysis and Outlook To 2030
9.1 Introduction to Europe Antimicrobial Resistance Surveillance Markets in 2024
9.2 Europe Antimicrobial Resistance Surveillance Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Antimicrobial Resistance Surveillance Market Size Outlook by Segments, 2021-2030
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
10 Asia Pacific Antimicrobial Resistance Surveillance Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Antimicrobial Resistance Surveillance Markets in 2024
10.2 Asia Pacific Antimicrobial Resistance Surveillance Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Antimicrobial Resistance Surveillance Market size Outlook by Segments, 2021-2030
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
11 South America Antimicrobial Resistance Surveillance Market Analysis and Outlook To 2030
11.1 Introduction to South America Antimicrobial Resistance Surveillance Markets in 2024
11.2 South America Antimicrobial Resistance Surveillance Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Antimicrobial Resistance Surveillance Market size Outlook by Segments, 2021-2030
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
12 Middle East and Africa Antimicrobial Resistance Surveillance Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Antimicrobial Resistance Surveillance Markets in 2024
12.2 Middle East and Africa Antimicrobial Resistance Surveillance Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Antimicrobial Resistance Surveillance Market size Outlook by Segments, 2021-2030
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Accelerate Diagnostics Inc
Alifax S.r.l.
Becton, Dickinson and Company
Bioanalyse GmbH
bioMérieux SA
Bio-Rad Laboratories Inc
BioSpace Inc
Bruker Corp
Danaher Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Liofilchem S.r.l.
Lumed LLC
Luminex Corp
Merck KGaA
OpGen Inc
QIAGEN N.V.
Thermo Fisher Scientific Inc
Wolters Kluwer N.V.
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
